+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America COVID-19 diagnostics Market 2020-2026

  • ID: 5190211
  • Report
  • October 2020
  • Region: Latin America
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Biologix Group Ltd.
  • CT Vacinas
  • Diagnos Med srl
  • Hi Technologies
  • MORE
Latin America COVID-19 diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026
Latin America COVID-19 diagnostics market is estimated to see a decline in CAGR of 19.5% during the forecast period. Latin America is especially susceptible to the coronavirus coupled with the high levels of poverty. Over 100 million people across Latin America and the Caribbean live in slums. On 14th July 2020, Chile, Brazil, Mexico, Peru, and Ecuador, reported the largest numbers of mortalities in the region. As a result, the government of Latin American countries took some initiatives to increase testing capacity that can support the prevention of further spread in the country. Several State governments of Latin America enhanced their testing capabilities. For instance, On July 2020, Ecuador declared the deployment of new sanitary mobile centers to accelerate testing and ease burden on the health system, challenged by a surge in COVID-19 cases.

Latin America COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others.

Latin America COVID-19 diagnostics market is segmented on the basis of countries, Mexico, Brazil, Argentina, Colombia, and Rest of Latin America. Brazil held the largest market value in the Latin America COVID-19 diagnostics market. Brazil was severely hit by COVID-19. On July 31, 2020, the Brazilian Ministry of Health declared that Brazil would offer support to the public through Google and Apple’s COVID-19 exposure notification API for iPhone and Android users. With this initiative, the Brazilians will get access to exposure alerts using the Coronavirus SUS app, which offers information regarding the status of COVID-19 pandemic and provides prevention tips. The patients who tested positive for coronavirus will get a unique token with the test outcome. This result can be uploaded on the Coronavirus SUS app which intends to alert other users with the app installed.

The companies which are contributing to the growth of the Latin America COVID-19 diagnostics market include Biolinker Synthetic Biology, Biologix Group Ltd., Hi Technologies, and Diagnos Med srl. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in June 2020, Researchers at Biolinker Synthetic Biology, a biotech startup based in São Paulo, Brazil, declared that it is developing a low-cost high-performance COVID-19 diagnostic test with the use of only locally sourced inputs. It will use a cell-free protein synthesis technology which is created by the firm over the last two years to leverage and improve protein production processes based on an in vitro transcription and translation system.

Research Methodology

The market study of the Latin America COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. Latin America COVID-19 Diagnostics Market Research and Analysis by Type
2. Latin America COVID-19 Diagnostics Market Research and Analysis by Technology Type
3. Latin America COVID-19 Diagnostics Market Research and Analysis by Sample Type
4. Latin America COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the Latin America COVID-19 diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Latin America COVID-19 diagnostics market.
  • Insights about market determinants which are stimulating the Latin America COVID-19 diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biologix Group Ltd.
  • CT Vacinas
  • Diagnos Med srl
  • Hi Technologies
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Latin America COVID-19 Diagnostics Market by Type
5.1.1. Instruments
5.1.2. Reagents & Kits
5.1.3. Laboratory Testing Services
5.2. Latin America COVID-19 Diagnostics Market by Technology Type
5.2.1. PCR Test
5.2.2. Antigen Test
5.2.2.1. Chromatographic Immunoassay
5.2.2.2. Fluorescent Immunoassay
5.2.2.3. Chemiluminescent Immunoassay
5.2.3. Serology Test
5.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3.2. Neutralization
5.2.3.3. Chemiluminescent Immunoassay
5.2.4. Rapid/ PoC Test
5.3. Latin America COVID-19 Diagnostics Market by Sample Type
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Blood
5.3.3. Urine
5.3.4. Saliva
5.3.5. Others (Sperm)
5.4. Latin America COVID-19 Diagnostics Market by End-Users
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Diagnostic Centers & Clinics
5.4.4. Research Institutes

6. Regional Analysis
6.1. Brazil
6.2. Argentina
6.3. Colombia
6.4. Mexico
6.5. Rest of Latin America

7. Company Profiles
7.1. Biolinker Synthetic Biology
7.2. Biologix Group Ltd.
7.3. CT Vacinas
7.4. Diagnos Med srl
7.5. Hi Technologies
7.6. Orangelife Comercio e Industria Ltd.

List of Tables

List of Figures
Note: Product cover images may vary from those shown
3 of 3
  • Biolinker Synthetic Biology
  • Biologix Group Ltd.
  • CT Vacinas
  • Diagnos Med srl
  • Hi Technologies
  • Orangelife Comercio e Industria Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll